Jeffrey L Bennett

16PUBLICATIONS
92CO-AUTHORS
Neurology and neuromuscular diseasesOptical technologyAutoimmunityDisease surveillancePain
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 13, 2026
Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

|Feb 11, 2026
Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series.

Paulus S Rommer, Wei Jiang, Jan P Nolte

|Oct 06, 2025
Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Jeffrey L Bennett, Kazuo Fujihara, Albert Saiz

|Aug 05, 2025
Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity.

Thanos Tsaktanis, Leander Ammon, Lena Lößlein

|Jul 31, 2025
Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Jeffrey L Bennett, Kazuo Fujihara, Albert Saiz

|Jul 25, 2025
Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Andrew B Wolf, Jacqueline Palace, Jeffrey L Bennett

Pageof 3

Frequent Collaborators

3 joint publications

Friedemann Paul

3 joint publications

Jacqueline Palace

3 joint publications

Kazuo Fujihara

3 joint publications

Michael Levy